SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RCMac who wrote (2764)5/14/1999 3:40:00 PM
From: Biomaven  Read Replies (2) of 10280
 
To clarify my position as well, I'm also in this for the long term and am holding all my shares.

It's unclear what percentage of the costs of Nori development that J&J have been paying (as is normal, this has been redacted in the 10-K version of the agreement).

If the drug has no problems, then SEPR could co-promote it with someone else, like maybe Glaxo. SEPR can't reasonably expect to effectively market this on its own.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News